C79.60 — Secondary malignant neoplasm of unspecified ovary
Is C79.60 billable?
Yes, but C79.60 is an unspecified code. C79.60 is a valid, billable ICD-10-CM code for encounters from October 1, 2026 through September 30, 2027. However, C79.60 is an unspecified or catch-all code. Payers apply additional scrutiny to unspecified codes and many deny them when the medical record supports a more specific option, so check the documentation before selecting C79.60 — the more specific alternatives are listed below.
C79.60 at a glance
| Code | C79.60 |
|---|---|
| Description | Secondary malignant neoplasm of unspecified ovary |
| Billable | Yes |
| Code set | ICD-10-CM FY2027 |
| Valid for encounters | October 1, 2026 – September 30, 2027 |
Which MS-DRGs does C79.60 group to?
C79.60 sits in MDC 13 and helps define the logic of 3 MS-DRGs (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.
- 731Uterine and Adnexa Procedures for Malignancy with MCCsurgical
- 732Uterine and Adnexa Procedures for Malignancy with CCsurgical
- 733Uterine and Adnexa Procedures for Malignancy without CC/MCCsurgical
As a secondary diagnosis, C79.60 is a complication or comorbidity (CC), which can move a stay into a higher-paying DRG.
How is C79.60 listed in the Alphabetic Index?
The Alphabetic Index lists these routes under C79.6, the nearest indexed parent of C79.60. Use them to find the family, then select the specific code.
- Krukenberg's › tumor
- Tumor › Krukenberg's
Excludes1 — never code together — inherited from C79
The conditions below can never be reported together with C79.60 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.
How long has C79.60 existed?
C79.60 has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.
Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.